Skip to main content

INTEGRACION FISIOLOGICA E IMPLICACIONES PATOLOGICAS DE LAS INTERACCIONES FUNCIONALES DE GRK2 EN DIFERENTES TIPOS Y CONTEXTOS CELULARES

SAF2014-55511-R

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2014
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Secretaría de Estado de Educación, Formación Profesional y Universidades
Beneficiary centre UNIVERSIDAD AUTONOMA DE MADRID

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

e-Archivo. Repositorio Institucional de la Universidad Carlos III de Madrid
Publication Artículo científico (JournalArticle)

Protein kinase C zeta Interacts with a novel binding region of Galfaq to act as a functional effector

  • Sánchez Fernández, Guzmán
  • Cabezudo, Sofia
  • Caballero, Álvaro
  • García Hoz, Carlota
  • Tall, Gregory G.
  • Klett Arroyo, Javier
  • Michnick, Stephen W.
  • Mayor Jr., Federico
  • Ribas, Catalina
Heterotrimeric G proteins play an essential role in the initiation of G protein-coupled receptor (GPCR) signaling through specific interactions with a variety of cellular effectors. We have recently reported that GPCR activation promotes a direct interaction between Galfaq and protein kinase C zeta (PKCzeta), leading to the stimulation of the ERK5 pathway independent of the canonical effector PLCbeta. We report herein that the activation-dependent Galfaq/PKCzeta complex involves the basic PB1-type II domain of PKCzeta and a novel interaction module in Galfaq different from the classical effector-binding site. Point mutations in this Galfaq region completely abrogate ERK5 phosphorylation, indicating that Galfaq/PKCzeta association is required for the activation of the pathway. Indeed, PKCzeta was demonstrated to directly bind ERK5 thus acting as a scaffold between Galfaq and ERK5 upon GPCR activation. The inhibition of these protein complexes by G protein-coupled receptor kinase 2, a known Galfaq modulator, led to a complete abrogation of ERK5 stimulation. Finally, we reveal that Galfaq/PKCzeta complexes link Galfaq to apoptotic cell death pathways. Our data suggest that the interaction between this novel region in Galfaq and the effector PKCzeta is a key event in Galfaq signaling.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Reversal of diet-induced obesity and insulin resistance by inducible genetic ablation of GRK2

  • Vila-Bedmar, Rocío
  • Cruces-Sande, Marta
  • Lucas, Elisa
  • Willemen, H. L. D. M
  • Heijnen, Cobi J.
  • Kavelaars, Anna Maria Agnes Antonius
  • Mayor Menéndez, Federico
  • Murga, Cristina
Insulin resistance is a common feature of obesity and predisposes individuals to various prevalent pathological conditions. G protein (heterotrimeric guanine nucleotide–binding protein)–coupled receptor kinase 2 (GRK2) integrates several signal transduction pathways and is emerging as a physiologically relevant inhibitor of insulin signaling. GRK2 abundance is increased in humans with metabolic syndrome and in different murine models of insulin resistance. To support GRK2 as a potential drug target in type 2 diabetes and obesity, we investigated whether lowering GRK2 abundance reversed an ongoing systemic insulin-resistant phenotype, using a mouse model of tamoxifen-induced GRK2 ablation after high-fat diet– dependent obesity and insulin resistance. Tamoxifen-triggered GRK2 deletion impeded further body weight gain, normalized fasting glycemia, improved glucose tolerance, and was associated with preserved insulin sensitivity in skeletal muscle and liver, thereby maintaining whole-body glucose homeostasis. Moreover, when continued to be fed a high-fat diet, these animals displayed reduced fat mass and smaller adipocytes, were resistant to the development of liver steatosis, and showed reduced expression of proinflammatory markers in the liver. Our results indicate that GRK2 acts as a hub to control metabolic functions in different tissues, which is key to controlling insulin resistance development in vivo. These data suggest that inhibiting GRK2 could reverse an established insulin-resistant and obese phenotype, thereby putting forward this enzyme as a potential therapeutic target linking glucose homeostasis and regulation of adiposity., This work was supported by grants SAF2014-55511-R (to F.M. and C.M.) from Ministerio de Economía y Competitividad (MINECO), Spain; S2010/BMD-2332 (INDISNET) from Comunidad de Madrid, Spain (to F.M.); the Cardiovascular Network (RD12/0042/0012) from Ministerio Sanidad y Consumo– Instituto Carlos III, Spain (to F.M.); a European Foundation for the Study of Diabetes Novo Nordisk Partnership for Diabetes Research in Europe Grant (to F.M.); Fundación Ramón Areces (to C.M.); the National Institute of Neurological Disorders and Stroke of the NIH under award numbers RO1NS073939 and RO1NS074999; and a STAR award of the University of Texas Systems. E.L. was a recipient of an FPU fellowship from Ministerio de Educación– Spain; M.C.-S. is a recipient of an FPI fellowship from Universidad Autónoma Madrid. We also acknowledge the support of a Contrato para la Formación Postdoctoral from MINECO and of a European Molecular Biology Organization short-term fellowship to R.V.-B., and institutional support from Fundación Ramón Areces., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Obesity-induced cardiac lipid accumulation in adult mice is modulated by G protein-coupled receptor kinase 2 levels

  • Lucas, Elisa
  • Vila-Bedmar, Rocío
  • Arcones, Alba C.
  • Cruces-Sande, Marta
  • Cachofeiro, Victoria
  • Mayor Menéndez, Federico
  • Murga, Cristina
[Background] The leading cause of death among the obese population is heart failure and stroke prompted by structural and functional changes in the heart. The molecular mechanisms that underlie obesity-related cardiac remodeling are complex, and include hemodynamic and metabolic alterations that ultimately affect the functionality of the myocardium. G protein-coupled receptor kinase 2 (GRK2) is an ubiquitous kinase able to desensitize the active form of several G protein-coupled receptors (GPCR) and is known to play an important role in cardiac GPCR modulation. GRK2 has also been recently identified as a negative modulator of insulin signaling and systemic insulin resistance., [Methods] We investigated the effects elicited by GRK2 downregulation in obesity-related cardiac remodeling. For this aim, we used 9 month-old wild type (WT) and GRK2+/− mice, which display circa 50% lower levels of this kinase, fed with either a standard or a high fat diet (HFD) for 30 weeks. In these mice we studied different parameters related to cardiac growth and lipid accumulation., [Results] We find that GRK2+/− mice are protected from obesity-promoted cardiac and cardiomyocyte hypertrophy and fibrosis. Moreover, the marked intracellular lipid accumulation caused by a HFD in the heart is not observed in these mice. Interestingly, HFD significantly increases cardiac GRK2 levels in WT but not in GRK2+/− mice, suggesting that the beneficial phenotype observed in hemizygous animals correlates with the maintenance of GRK2 levels below a pathological threshold. Low GRK2 protein levels are able to keep the PKA/CREB pathway active and to prevent HFD-induced downregulation of key fatty acid metabolism modulators such as Peroxisome proliferator-activated receptor gamma co-activators (PGC1), thus preserving the expression of cardioprotective proteins such as mitochondrial fusion markers mitofusin MFN1 and OPA1., [Conclusions] Our data further define the cellular processes and molecular mechanisms by which GRK2 down-regulation is cardioprotective during diet-induced obesity, reinforcing the protective effect of maintaining low levels of GRK2 under nutritional stress, and showing a role for this kinase in obesity-induced cardiac remodeling and steatosis., This work was supported by the Spanish Ministerio de Economía y Competitividad (MINECO, Grant SAF2014-55511-R to F. M and C. M); Fundación Ramón Areces (to C. M.); Comunidad de Madrid Grant S2010/BMD-2332 (Inter-Disciplinary Research Network); Ministerio Sanidad y Consumo-Instituto Carlos III Cardiovascular Network (Grant RD12/0042/0012 to F. M. and RD12/0042/0033 (to V. C.); and PI15/01060 (to V. C.). R. V. B. is recipient of a postdoctoral contract by the MINECO. We acknowledge the support of the publication fee by the CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Involvement of G protein-coupled receptor kinase 2 (GRK2) in the development of non-alcoholic steatosis and steatohepatitis in mice and humans

  • Cruces-Sande, Marta
  • Vila-Bedmar, Rocío
  • Arcones, Alba C.
  • González-Rodríguez, Águeda
  • Rada, Patricia
  • Gutiérrez-de-Juan, Virginia
  • Vargas-Castrillón, Javier
  • Iruzubieta, Paula
  • Sánchez-González, Cristina
  • Formentini, Laura
  • Crespo, Javier
  • García-Monzón, Carmelo
  • Martínez-Chantar, María Luz
  • Valverde, Ángela M.
  • Mayor Jr., Federico
  • Murga, Cristina
Insulin resistance (IR) and obesity are important risk factors for non-alcoholic fatty liver disease (NAFLD). G protein-coupled receptor kinase 2 (GRK2) is involved in the development of IR and obesity in vivo. However, its possible contribution to NAFLD and/or non-alcoholic steatohepatitis (NASH) independently of its role on IR or fat mass accretion has not been explored. Here, we used wild-type (WT) or GRK2 hemizygous (GRK2±) mice fed a high-fat diet (HFD) or a methionine and choline-deficient diet (MCD) as a model of NASH independent of adiposity and IR. GRK2± mice were protected from HFD-induced NAFLD. Moreover, MCD feeding caused an increased in triglyceride content and liver-to-body weight ratio in WT mice, features that were attenuated in GRK2± mice. According to their NAFLD activity score, MCD-fed GRK2± mice were diagnosed with simple steatosis and not overt NASH. They also showed reduced expression of lipogenic and lipid-uptake markers and less signs of inflammation in the liver. GRK2± mice preserved hepatic protective mechanisms as enhanced autophagy and mitochondrial fusion and biogenesis, together with reduced endoplasmic reticulum stress. GRK2 protein was increased in MCD-fed WT but not in GRK2± mice, and enhanced GRK2 expression potentiated palmitic acid-triggered lipid accumulation in human hepatocytes directly relating GRK2 levels to steatosis. GRK2 protein and mRNA levels were increased in human liver biopsies from simple steatosis or NASH patients in two different human cohorts. Our results describe a functional relationship between GRK2 levels and hepatic lipid accumulation and implicate GRK2 in the establishment and/or development of NASH., Ministerio de Economia y Competitividad (MINECO/FEDER), Spain (grants SAF2014-55511-R and SAF2017-84125-R to F.M and C. M., grant SAF2015-65267-R to A.M.V., grant SAF2016-76028R to L.F. and SAF2017-87301-R to M.L.M.-C); Comunidad de Madrid-B2017/BMD-3671-INFLAMUNE to F.M.; Gobierno Vasco-Departamento de Salud 2013111114 and EITB Maratoia BIO15/CA/014 (to M.L.M.C); European Foundation for the Study of Diabetes (EFSD) Novo Nordisk Partnership for Diabetes Research in Europe Grant (to F.M.); Asociacion Espanola contra el Cancer (M.L.M-C) and Fundacion Ramon Areces (to C.M.). Instituto de Salud Carlos III (with European FEDER contribution) funds CIBERCV (grant CB16/11/00278 to F.M), CIBERDEM and CIBERehd, Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Sex differences in high fat diet-induced metabolic alterations correlate with changes in the modulation of GRK2 levels

  • Arcones, Alba C.
  • Cruces-Sande, Marta
  • Ramos Parrón, Paula
  • Mayor Menéndez, Federico
  • Murga, Cristina
A differential sex-related sensitivity has been reported in obesity and insulin resistance-related cardio-metabolic diseases, with a lower incidence of these pathologies being observed in young females when compared to age-matched males. However, such relative protection is lost with age. The mechanisms underlying such sex and age-related changes in the susceptibility to diabetes and obesity are not fully understood. Herein, we report that the relative protection that is displayed by young female mice, as compared to male littermates, against some of the metabolic alterations that are induced by feeding a high fat diet (HFD), correlates with a lower upregulation of the protein levels of G protein-coupled receptor kinase (GRK2), which is a key regulator of both insulin and G protein-coupled receptor signaling, in the liver and adipose tissue. Interestingly, when the HFD is initiated in middle-aged (32 weeks) female mice, these animals are no longer protected and display a more overt obese and insulin-resistant phenotype, along with a more evident increase in the GRK2 protein levels in metabolically relevant tissues in such conditions. Our data suggest that GRK2 dosage might be involved in the sex and age-biased sensitivity to insulin resistance-related pathologies., Agencia Estatal de Investigación of Spain (grant SAF2014-55511-R and SAF2017-84125-R to F.M.J. and C.M.), CIBERCV-Instituto de Salud Carlos III, Spain (grant CB16/11/00278 to F.M., co-funded with European Regional Development Fund-FEDER contribution), Programa de Actividades en Biomedicina de la Comunidad de Madrid (grant B2017/BMD-3671-INFLAMUNE to F.M.J.) and Fundación Ramón Areces., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

G‐protein‐coupled receptor kinase 2 safeguards epithelial phenotype in head and neck squamous cell carcinomas

  • Palacios-García, Julia
  • Sanz-Flores, María
  • Asensio, Alejandro
  • Alvarado, Raul
  • Rojo-Berciano, Susana
  • Stamatakis, Konstantinos
  • Paramio, Jesús M.
  • Cano, Amparo
  • Nieto, M. Ángela
  • García-Escudero, Ramón
  • Mayor Jr., Federico
  • Ribas, Catalina
Head and neck squamous cell carcinoma (HNSCC) arises from the mucosal lining of the upper aerodigestive tract and display few treatment options in advanced stages. Despite increased knowledge of HNSCC molecular biology, the identification of new players involved in triggering HNSCC recurrence and metastatic disease is needed. We uncover that G‐protein‐coupled receptor kinase‐2 (GRK2) expression is reduced in undifferentiated, high‐grade human HNSCC tumors, whereas its silencing in model human HNSCC cells is sufficient to trigger epithelial‐to‐mesenchymal transition (EMT) phenotypic features, an EMT‐like transcriptional program and enhanced lymph node colonization from orthotopic tongue tumors in mice. Conversely, enhancing GRK2 expression counteracts mesenchymal cells traits by mechanisms involving phosphorylation and decreased functionality of the key EMT inducer Snail1. Our results suggest that GRK2 safeguards the epithelial phenotype, whereas its downregulation contributes to the activation of EMT programs in HNSCC., Our laboratories are supported by Agencia Estatal de Investigación of Spain (grants SAF2014‐55511‐R and SAF2017‐84125‐R to F.M.; SAF2015‐66015‐R and ISCIII PIE15/00081 to J.P.M.; SAF2016‐76504‐R to A.C. and BFU2014‐53128‐R to M.A.N.); CIBERCV‐Instituto de Salud Carlos III, Spain (grant CB16/11/00278 to F.M., co‐funded with European FEDER contribution), CIBERONC‐Instituto de Salud Carlos III (grant CB16/12/00228 and CB16/12/00295 to J.M.P. and A.C., respectively, co‐funded with European FEDER contribution); Instituto de Salud Carlos III, Spain (grant PI14/00201 and PI18/01662 to C.R.; PI18/00263 to R.G.E., co‐funded with European FEDER contribution) and Fundación Ramón Areces (to C.R and F.M.), Swiss National Science Foundation (grant 144637, 153099), Swiss Cancer League (grant KLS 3243‐08‐2013) and Fundacion Anemia de Fanconi (grant 2018/127) to R.G.E.; and Programa de Actividades en Biomedicina de la Comunidad de Madrid‐B2017/BMD‐3671‐INFLAMUNE to F.M. M.S.F. was recipient of a Postdoctoral fellowship from Comunidad de Madrid (PEFD‐2017‐POST/BMD‐4442) and A.A. holds a PhD Fellowship from FPI programme Agencia Estatal de Investigación (PRE2018‐084418). We also acknowledge institutional support to the CBMSO from Fundación Ramón Areces., Peer reviewed